Just-in-time cell-free expression of fresh target proteins
Flexible array content
Proteins produced by human ribosomes and chaperone proteins, ensuring natural folding
Consistent protein levels across arrays
Room temperature stable
and ready for use
Compatible with orthogonal immunoassays for verification
Ordinatrix builds on over a decade of development and refinement of the Nucleic Acid Programmable Protein Arrays (NAPPA) technology. Ordinatrix provides a customizable solution for analysis of the proteome with the commercial introduction of the Nucleic Acid Programmable Protein Arrays (NAPPA) platform. Our just-in-time protein production process allows us to provide customers with the screening of the complete human proteome comprising over 18,000 unique proteins, or selective target proteins of their choosing at the time of order.
Ordinatrix holds exclusive worldwide licenses to the NAPPA technology through licensing agreements with Arizona State University.
Our mission is to be the leader in translational proteomics through the creation of the most functional, flexible, and precise protein microarrays in the industry based on our attention to quality, intellectual property, and many years of experience with the Nucleic Acid Programmable Protein Arrays (NAPPA) technology, which will aid in the development of new drugs, diagnosis of disease and approaches to personalized medicine.